摘要
目的探讨新活素联合左西孟旦治疗难治性心力衰竭的临床效果。方法选取2016年2月至2017年2月到某院进行难治性心力衰竭疾病治疗的患者100例,将100例患者随机分为两组,对两组患者选择合适的新活素进行常规的治疗,实验组患者在使用新活素治疗的基础上,使用左西孟坦对患者进行治疗,观察两组患者治疗前后心率变化、呼吸变化以及尿量的变化;观察并记录两组患者治疗前后BNP、PRA变化。结果治疗后实验组心率降低,呼吸减慢,尿量增加,显著优于对照组,有统计学意义(P<0.05),治疗后实验组的BNP与PRA现在降低,显著优于治疗前及对照组,有统计学意义(P<0.05)。结论对难治性心力衰竭疾病的治疗,使用新活素联合左西孟旦进行治疗,具有更好的治疗效果。
Objective To explore the clinical effect of new living hormone combined with levosimendan in the treatment of refractory heart failure. Methods 100 patients were selected from February 2016-February 2017 year in February to a hospital for treatment of intractable heart failure disease, 100 patients were randomly divided into two groups, the new live selection of two groups of patients in routine treatment, patients in the experimental group based on the use of nesiritide therapy,the treatment of patients with levosimendan, observe the changes of heart rate, two groups of patients before and after treatment of respiratory changes, and changes in the amount of urine; observe and record the two groups of patients before and after treatment BNP, PRA changes. Results After treatment, heart rate decreased,respiration slowed down and urine volume increased in the experimental group, which was significantly better than that in the control group. There was a statistical significance(P<0.05). After treatment, the BNP and PRA in the experimental group decreased, which was significantly better than that in the control group before treatment(P<0.05). Conclusion The treatment of refractory heart failure with new living hormone combined with levosimendan has a better therapeutic effect.
引文
[1]卞静,宋涛,赵严,等.新活素联合左西孟旦治疗难治性心衰的临床研究[J].当代医学,2018,24(3):50-53.
[2]诸小飞,陆躖.左西孟旦治疗缺血性心肌病并顽固性心力衰竭疗效观察[J].心脑血管病防治,2017,17(6):446-447.
[3]全银姬.急性心肌梗死合并心力衰竭应用新活素治疗效果分析[J].世界复合医学,2017,3(3):70-72.
[4]何丽,王艺鹏.新活素联合左西孟旦治疗慢性心衰急性发作的临床效果[J].临床医学研究与实践,2017,2(17):11-13.
[5]陈会校,张强,柴巧英,等.新活素联合左西孟旦对顽固性心力衰竭的临床研究[J].世界最新医学信息文摘(连续型电子期刊),2017,17(3):34.
[6]包春辉.慢性心力衰竭应用新活素、左西孟旦和托伐普坦联合治疗的疗效分析[J].中国卫生标准管理,2016,7(16):102-104.
[7]张锐.左西孟旦与新活素治疗急性左心衰竭疗效对比[J].世界最新医学信息文摘(连续型电子期刊),2016,16(8):165.
[8]刘斌.新活素、左西孟旦和托伐普坦联合应用治疗顽固性心力衰竭疗效观察[J].国际心血管病杂志,2015,42(6):431-432.
